EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action – EPIX

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, inclusive (the “Class Period”), of the important March 25, 2025 lead plaintiff deadline. SO WHAT: If you purchased ESSA Pharma Inc. securities […]
Read more